Sevcan Tuğ Bozdoğan

Sevcan Tuğ Bozdoğan

Auto-generated profile, based on publicly available information

Sevcan Tuğ Bozdoğan

Department of Medical Genetics, Faculty of Medicine, Çukurova University, Adana, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2022 in Genes
Verified
Journal Article
Open access
PDF file
AOAlessandro Orsini
Alessandro Orsini
ASAndrea Santangelo
Andrea Santangelo
FBFrancesca Bravin
Francesca Bravin
ABAlice Bonuccelli
Alice Bonuccelli
DPDIEGO PERONI
DIEGO PERONI
DCDuccio Maria Cordelli
Duccio Maria Cordelli
Background: Poirier–Bienvenu Neurodevelopmental Syndrome (POBINDS) is a rare disease linked to mutations of the CSNK2B gene, which encodes for a subunit of caseinkinase CK2 involved in neuronal growth and synaptic transmission. Its main features include early-onset epilepsy and intellectual disability. Despite the lack of cases described, it appears that POBINDS could manifest with a wide range of phenotypes, possibly related to the different mutations of CSNK2B. Methods: Our multicentric, retrospective study recruited nine patients with POBINDS, detected using next-generation sequencing panels and whole-exome sequencing. Clinical, laboratory, and neuroimaging data were reported for each patient in order to assess the severity of phenotype, and eventually, a correlation with the type of CSNK2B mutation. Results: We reported nine unrelated patients with heterozygous de novo mutations of the CSNK2B gene. All cases presented epilepsy, and eight patients were associated with a different degree of intellectual disability. Other features detected included endocrinological and vascular abnormalities and dysmorphisms. Genetic analysis revealed six new variants of CSNK2B that have not been reported previously. Conclusion: Although it was not possible to assess a genotype–phenotype correlation in our patients, our research further expands the phenotype spectrum of POBINDS patients, identifying new mutations occurring in the CSNK2B gene.

13 June 2014 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Open access
PDF file
SBSevcan Tug Bozdogan
Sevcan Tug Bozdogan
OYOzge Ozalp Yuregir
Ozge Ozalp Yuregir
NBNurhilal Buyukkurt
Nurhilal Buyukkurt
HAHuseyin Aslan
Huseyin Aslan
ZOZeynep Canan Ozdemir
Zeynep Canan Ozdemir
TGTomasz Gambin
Tomasz Gambin
To look over the distribution of the mutations in a large series from Adana province, Southern Turkey, and determine the genotype-phenotype correlation of the frequent mutations. Among the 2500 individuals with mild or moderate anemia, microcytosis, and normal iron levels that were referred to our Genetic Diagnosis Center, a population consisting of 539 individuals were included in the study and tested for alpha-thalassemia mutations by using reverse dot blot hybridization technique. Twelve different mutations were detected in 539 patients. Among the 12 different mutations found, the most frequent mutations were the –α3.7 (63.3 %), --MED (11.7 %), --20.5 (10.7 %), α2IVS1(−5nt) (3.9 %), and α2polyA−2 (3.5 %). The most frequent genotypes were –α3.7/αα (35.8 %), –α3.7/-α3.7(18.9 %), –20.5/αα (11.5 %), and --MED/αα (10.4 %), respectively. There were statistically significant differences in hematological findings between –α3.7/–α3.7 and --MED/αα, even though both have two mutated genes in the genotype. Our results show that alpha-thalassemia mutations are highly heterogeneous as well as deletional and –α3.7 single gene deletion is particularly prevalent at Adana province in agreement to other studies from Turkey.

6 July 2017 in Journal of Pediatric Genetics
Verified
Journal Article
Closed access
PDF file
ABAtil Bisgin
Atil Bisgin
SBSevcan Tug Bozdogan
Sevcan Tug Bozdogan
Down's syndrome has its own dysmorphic findings and is accompanied by mental retardation and hypotonia. Klinefelter's syndrome is a syndrome caused by a numerical abnormality that affects male physical and cognitive development. This case reports a unique finding of 48,XXY, + 21 and a current literature review. A 4-month-old male patient presented with typical clinical features of Down's syndrome with hypothyroidism, atrial septal defect, ventricular septal defect, and patent ductus arteriosus without any phenotypic signs of Klinefelter's syndrome.

31 January 2021 in Genes
Verified
Journal Article
Open access
PDF file
SBSevcan Tug Bozdogan
Sevcan Tug Bozdogan
CMCem Mujde
Cem Mujde
IBIbrahim Boga
Ibrahim Boga
OSOzge Sonmezler
Ozge Sonmezler
AHAbdullah HANTA
Abdullah HANTA
ABAtıl Bışgın
Atıl Bışgın
Background: Cystic fibrosis (CF) is the most common worldwide, life-shortening multisystem hereditary disease, with an autosomal recessive inheritance pattern caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The national newborn screening (NBS) program for CF has been initiated in Turkey since 2015. If the immunoreactive trypsinogen (IRT) is elevated (higher than 70 μg/L in the second control) and confirmed by sweat test or clinical findings, genetic testing is performed. The aims of this study are to emphasize the effect of NBS on the status of genetic diagnosis centers with the increasing numbers of molecular testing methods, and to determine the numbers and types of CFTR mutations in Turkey. Methods: The next-generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) results of 1595 newborns, who were referred to Cukurova University Adana Genetic Diseases Diagnosis and Treatment Center (AGENTEM) for molecular genetic testing, were evaluated with positive CF NBS program results since 2017. Results: According to the results; 560 (35.1%) of the 1595 patients carried at least 1 (one) CF-related variant, while 1035 patients (64.9%) had no mutation. Compound heterozygosity for two mutations was the most common in patients, while two detected variants were homozygote in 14 patients. A total of 161 variants were detected in 561 patients with mutations. Fifteen novel variants that have not been previously reported were found. Moreover, p.L997F was identified as the most frequent pathogenic mutation that might affect the IRT measurements used for the NBS. The distribution of mutation frequencies in our study showed a difference from those previously reported; for example, the well-known p.F508del was the third most common (n = 42 alleles), rather than the first. The most striking finding is that 313 cases had a pathogenic variant together with the V470M variant, which might have a cumulative effect on CF perpetuation. Conclusion: This study is the first to determine the mutational spectrum of CFTR in correlation with the NBS program in the Turkish population. NBS for CF raises issues regarding screening in diverse populations, both medical and non-medical benefits, and carrier identification. Through the lens of NBS, we focused on the integrated diagnostic algorithms and their effect on the results of genetic testing.

24 October 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
GKGökhan Kuran
Gökhan Kuran
HAHüseyin Aslan
Hüseyin Aslan
SHSüheyl Haytoğlu
Süheyl Haytoğlu
OOOzge Ozalp
Ozge Ozalp
SBSevcan Tuğ Bozdoğan
Sevcan Tuğ Bozdoğan
Sinonasal polyposis is a complex chronic disease displaying contributions from multiple genetic and environmental factors. In this study, we analyzed possible genetic factors that increase susceptibility to this widespread inflammatory disease. A total of 176 adult patients, including 78 patients with sinonasal polyposis and 98 healthy controls, were analyzed for IL-1RN VNTR, IL-2(-330), and IL-4 VNTR gene polymorphisms using polymerase chain reaction and enzyme restriction. IL-1RN and IL-4 VNTR polymorphisms were notably associated with sinonasal polyposis (P = 0.0001 and P = 0.036, respectively); however, regarding the IL-2(-330) gene polymorphism, no significant difference was shown between the patient and control groups (P = 0.235). Our study indicates that the RN2 allele of IL-1RN and the RP1 allele of IL-4 might be risk factors for developing sinonasal polyposis.

23 August 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
BGBegümhan Demir Gündoğan
Begümhan Demir Gündoğan
FSFatih Sağcan
Fatih Sağcan
SBSevcan Tuğ Bozdoğan
Sevcan Tuğ Bozdoğan
YBYüksel Balcı
Yüksel Balcı
FDFerah Tuncel Daloğlu
Ferah Tuncel Daloğlu
EÇElvan Cağlar Çıtak
Elvan Cağlar Çıtak
Cases of neurofibromatosis type 1 (NF1)-associated medullary thyroid carcinoma (MTC) or C-cell hyperplasia are rarely associated with other endocrine tumors or cases with a multiple endocrine neoplasia type 2. In these patients, mutations were detected in the NF1 gene but no mutations were detected in the RET gene. Although vandetanib has been shown to improve progression-free survival in adults with advanced MTC, data in pediatric patients are limited. Herein, we report the use and outcome of vandetanib in a pediatric MTC case in which NF1 gene and RET proto-oncogen mutation were identified together.